Using advanced MRI to assess how well radiation treatment works for cervical cancer
Advanced diffusion MRI for evaluating early response to radiation treatment in cervical cancer
This study is looking at a new, safer way to see how well treatments are working for cervical cancer patients by using special MRI techniques that don’t involve radiation, helping doctors tell apart less serious and more serious cases early on to plan the best care for you.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11056761 on NIH RePORTER |
What this research studies
This research focuses on improving the evaluation of treatment responses in cervical cancer patients using advanced diffusion MRI techniques. By utilizing noninvasive biomarkers, the study aims to differentiate between less aggressive and more serious forms of the disease early on, which is crucial for effective treatment planning. The approach avoids the use of radiation and contrast agents, making it safer for patients. The goal is to develop a method that accurately reflects tumor burden and treatment response shortly after radiation therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with early-stage cervical cancer who are undergoing radiation treatment.
Not a fit: Patients with advanced cervical cancer or those not receiving radiation therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment strategies for cervical cancer patients, potentially reducing treatment-related complications.
How similar studies have performed: Previous studies have shown promise in using advanced imaging techniques for cancer evaluation, suggesting that this approach could be effective.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Rakow-Penner, Rebecca Ann — University of California, San Diego
- Study coordinator: Rakow-Penner, Rebecca Ann
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.